CK-0807

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCK-0807

Drug Alias NameCK-0807

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsLymphoma, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellenkos Inc

China Registration ClassN/A

Develop Information

Active CompaniesCellenkos Inc

Inactive CompaniesN/A

Active IndicationsLymphoma, T-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A